Dear colleagues and friends,

It’s our great pleasure to announce that Extracorporeal Life Support (ECLS) has been launched and will soon be released on-line. On behalf of our editorial group, I would like to say ‘thank you’ for your support of this journal.

Although tremendous efforts have been dedicated to basic and clinical research in the field of extracorporeal life support, very few academic journals have focused primarily on the research and clinical application of this technology. The launch of the ECLS journal comes in response to increasing demand from clinicians and scientists for a dedicated academic platform in which ground-breaking research and expert clinical opinion of extracorporeal life support can be shared and discussed.

With regard to the scope of the journal, it will cover extracorporeal support of circulation and respiratory failure, as well as its use in extra-cardiopulmonary organ failures. The ECLS journal will be looking for the most up-to-date and impactful research in extracorporeal life support, running the gamut from physiological to epidemiological studies, and including such topics as extracorporeal cardiopulmonary resuscitation, donor organ optimization, and advances in perfusion technology, among other novel and emerging areas.

We would like to pay special tribute to all the pioneers and predecessors who have devoted great time and efforts to the development of extracorporeal life support. It is their devotion and guidance that have led us to this exciting time. Back in 1972, Dr. Robert Bartlett became the pioneer of modern extracorporeal life support technology when he applied ECLS technology to clinical practice for the very first time. While initial clinical trials were unsuccessful, advances in extracorporeal technology, coupled with more comprehensive understanding of the pathophysiology of cardiopulmonary failure, have led to marked improvement in clinical outcomes and reductions in associated complications. This whole process has been made possible by the perseverance, dedication, scientific curiosity, and clinical acumen of those who first embarked into the field of extracorporeal support.

ECLS will be like a curious young man who is keen on discovering the unknowns in life. As told by Wang Xiaobo, the author of The Golden Age, “We crave for love, we crave for food, and we want to become the clouds above the sky, whether it’s in the light or the dark.’’ As for ECLS, this is the golden age. I hope all of you can find the same degree of excitement and motivation in ECLS as we do.

Best Regards,


The author would like to express sincere appreciation to Vicky Wong and Brad Li, Science Editor from Hong Kong Division, AME Publishing Company for their efforts to translate the Foreword from Chinese into English as well as to Dr. Daniel Brodie (Columbia College of Physicians and Surgeons) and Prof. Heidi J. Dalton (INOVA Fairfax Medical Center, Virginia) for their generous help to improve the Foreword.

Bingyang Ji

Bingyang Ji; on behalf of the editorial board

Department of Cardiopulmonary Bypass, State Key Laboratory of Cardiovascular Medicine, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China

doi: 10.21037/ecls.2017.04.01

Conflicts of Interest: The author has no conflicts of interest to declare.

doi: 10.21037/ecls.2017.04.01
Cite this article as: Ji B. Foreword. Extracorpor Life Support 2017;1:1.